Knowing that PGE2 can be found at high levels in the blood of melanoma patients (data not shown) we hypothesize that circulating PGE2 might fine-tune blood monocytes to acquire a suppressive phenotype, mediate CCR5 expression, and facilitate their recruitment into the tumor tissue. The gene discussed is CCR5; the disease is melanoma.